Improving medication adherence in diabetes type 2 patients through Real Time Medication Monitoring: a Randomised Controlled Trial to evaluate the effect of monitoring patients' medication use combined with short message service (SMS) reminders

被引:69
作者
Vervloet, Marcia [1 ]
van Dijk, Liset [1 ]
Santen-Reestman, Jacqueline [2 ]
van Vlijmen, Bas [2 ]
Bouvy, Marcel L. [3 ]
de Bakker, Dinny H. [1 ,4 ]
机构
[1] Netherlands Inst Hlth Serv Res, NIVEL, NL-3500 BN Utrecht, Netherlands
[2] Mediq Apotheken, NL-3500 GL Utrecht, Netherlands
[3] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, NL-3508 TB Utrecht, Netherlands
[4] Tilburg Univ, Sci Ctr Transformat Care & Welf, NL-5000 LE Tilburg, Netherlands
来源
BMC HEALTH SERVICES RESEARCH | 2011年 / 11卷
关键词
UNINTENTIONAL NONADHERENCE; HOSPITALIZATION; ASSOCIATION; INTERVENTIONS; POPULATION; MORTALITY; PLASMA; IMPACT; CARE;
D O I
10.1186/1472-6963-11-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Innovative approaches are needed to support patients' adherence to drug therapy. The Real Time Medication Monitoring (RTMM) system offers real time monitoring of patients' medication use combined with short message service (SMS) reminders if patients forget to take their medication. This combination of monitoring and tailored reminders provides opportunities to improve adherence. This article describes the design of an intervention study aimed at evaluating the effect of RTMM on adherence to oral antidiabetics. Methods/Design: Randomised Controlled Trial (RCT) with two intervention arms and one control arm involving diabetes type 2 patients with suboptimal levels of adherence to oral antidiabetics (less than 80% based on pharmacy refill data). Patients in the first intervention arm use RTMM including SMS reminders and a personal webpage where they can monitor their medication use. Patients in the second intervention arm use RTMM without SMS reminders or webpage access. Patients in the control arm are not exposed to any intervention. Patients are randomly assigned to one of the three arms. The intervention lasts for six months. Pharmacy refill data of all patients are available from 11 months before, until 11 months after the start of the intervention. Primary outcome measure is adherence to oral antidiabetics calculated from: 1) data collected with RTMM, as a percentage of medication taken as prescribed, and as percentage of medication taken within the correct time interval, 2) refill data, taking the number of days for which oral antidiabetics are dispensed during the study period divided by the total number of days of the study period. Differences in adherence between the intervention groups and control group are studied using refill data. Differences in adherence between the two intervention groups are studied using RTMM data. Discussion: The intervention described in this article consists of providing RTMM to patients with suboptimal adherence levels. This system combines real time monitoring of medication use with SMS reminders if medication is forgotten. If RTMM proves to be effective, it can be considered for use in various patient populations to support patients with their medication use and improve their adherence. Trial registration:
引用
收藏
页数:8
相关论文
共 41 条
  • [31] Experiences of barriers to self-monitoring and medication-management among Indian patients with type 2 diabetes, their primary family-members and physicians
    Chittem, Mahati
    Sridharan, Subha Gomathy
    Pongener, Matsungshila
    Maya, Sravannthi
    Epton, Tracy
    CHRONIC ILLNESS, 2022, 18 (03) : 677 - 690
  • [32] Development and Evaluation of a Tailored Mobile Health Intervention to Improve Medication Adherence in Black Patients With Uncontrolled Hypertension and Type 2 Diabetes: Pilot Randomized Feasibility Trial
    Schoenthaler, Antoinette
    Leon, Michelle
    Butler, Mark
    Steinhaeuser, Karsten
    Wardzinski, William
    JMIR MHEALTH AND UHEALTH, 2020, 8 (09):
  • [33] Effect of medication adherence on long-term all-cause-mortality and hospitalization for cardiovascular disease in 65,067 newly diagnosed type 2 diabetes patients
    Kim, Yeon-Yong
    Lee, Jin-Seok
    Kang, Hee-Jin
    Park, Sang Min
    SCIENTIFIC REPORTS, 2018, 8
  • [34] The Influence of Wireless Self-Monitoring Program on the Relationship Between Patient Activation and Health Behaviors, Medication Adherence, and Blood Pressure Levels in Hypertensive Patients: A Substudy of a Randomized Controlled Trial
    Kim, Ju Young
    Wineinger, Nathan. E.
    Steinhubl, Steven. R.
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2016, 18 (06)
  • [35] Short-term impact of co-payment level increase on the use of medication and patient-reported outcomes in Finnish patients with type 2 diabetes
    Lavikainen, Piia
    Aarnio, Emma
    Niskanen, Leo
    Mantyselka, Pekka
    Martikainen, Janne
    HEALTH POLICY, 2020, 124 (12) : 1310 - 1316
  • [36] Does self monitoring of blood glucose as opposed to urinalysis provide additional benefit in patients newly diagnosed with type 2 diabetes receiving structured education? The DESMOND SMBG randomised controlled trial protocol
    Dallosso, Helen M.
    Eborall, Helen C.
    Daly, Heather
    Martin-Stacey, Lorraine
    Speight, Jane
    Realf, Kathryn
    Carey, Marian E.
    Campbell, Michael J.
    Dixon, Simon
    Khunti, Kamlesh
    Davies, Melanie J.
    Heller, Simon
    BMC FAMILY PRACTICE, 2012, 13
  • [37] The Efficacy and Safety of Chinese Herbal Medicine Jinlida as Add-On Medication in Type 2 Diabetes Patients Ineffectively Managed by Metformin Monotherapy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial
    Lian, Fengmei
    Tian, Jiaxing
    Chen, Xinyan
    Li, Zhibin
    Piao, Chunli
    Guo, Junjie
    Ma, Licheng
    Zhao, Lijuan
    Xia, Chengdong
    Wang, Chong-Zhi
    Yuan, Chun-Su
    Tong, Xiaolin
    PLOS ONE, 2015, 10 (06):
  • [38] Use of Real-Time Continuous Glucose Monitoring Improves Glycemic Control and Other Clinical Outcomes in Type 2 Diabetes Patients Treated with Less Intensive Therapy
    Grace, Thomas
    Salyer, Jay
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 (01) : 26 - 31
  • [39] Impact of a clinical pharmacist on optimising the quality use of medicines according to the acute coronary syndrome (ACS) secondary prevention guidelines and medication adherence following discharge in patients with ACS in Sri Lanka: a prospective non-randomised controlled trial study protocol
    Bagyawantha, Nanayakkara Muhandiramalaya Yasakalum
    Coombes, Ian D.
    Gawarammana, Indika
    Fahim, Mohamed
    BMJ OPEN, 2023, 13 (02):
  • [40] A monitoring and feedback tool embedded in a counselling protocol to increase physical activity of patients with COPD or type 2 diabetes in primary care: study protocol of a three-arm cluster randomised controlled trial
    Verwey, Renee
    van der Weegen, Sanne
    Spreeuwenberg, Marieke
    Tange, Huibert
    van der Weijden, Trudy
    de Witte, Luc
    BMC FAMILY PRACTICE, 2014, 15